Abstract
Dengue fever and dengue haemorrhagic fever have emerged as a global public health problem in recent decades. The practice of platelet transfusion has been adapted into the standard clinical practice in management of hospitalized dengue patients. The exact indications and situations in which platelet have to be transfused may vary greatly. Blood components especially platelet concentrates due to their short shelf life are frequently in limited supply. Hence, appropriate use of blood is required to ensure the availability of blood for patients in whom it is really indicated, as well as to avoid unnecessary exposure of the patients to the risk of transfusion reactions and transmission of blood borne infection. The present study was conducted to evaluate the appropriateness of platelet transfusion done in dengue patients with thrombocytopenia. The present study was conducted on 343 serologically confirmed dengue patients admitted at JSS University Hospital between 1st January and 30th August 2009. Clinical data, platelet count and platelet requirements were analyzed. Among the 343 serologically confirmed cases, the prevalence of thrombocytopenia (platelet count < 100,000/cumm) was 64.72% (222 patients) and bleeding manifestations were recorded in 6.12% (21 patients). 71 (20.7%) patients of dengue cases received platelet transfusion. Among them 34 (47.89%) patients had a platelet count <20,000/cumm, 28 patients (39.44%) had platelet counts in the range of 21–40,000/cumm while the remaining 9 (12.67%) patients had platelet count between 41–100,000/cumm. Out of 37 patients with a platelet count >20,000/cumm 11 patients had haemorrhagic manifestations such as petechiae, gum bleeding, epistaxis etc., which necessitates the use of platelet transfusion. However, the remaining 26 patients with platelet count >20,000/cumm and with no haemorrhagic manifestations received inappropriate platelet transfusion. Transfusion of 36.62% of platelet concentrate was inappropriate. The study emphasizes the need for development of specific guidelines for transfusion of blood components, constant interaction and co-ordination amongst clinicians and transfusion centre for implementation of these guidelines and a regular medical audit to review the optimal utilization of blood components.
Similar content being viewed by others
References
Makroo RN, Raina V, Kumar P, Kanth RK (2007) Role of platelet transfusion in the management of dengue patients in a tertiary care Hospital. Asian J Trans Sci 1:4–7
Thomas A, Contreras M, Knowles S (1991) Blood component treatment: a retrospective audit in fine major hospitals. J Clin Pathol 44:734–739
Verma A, Agarwal P (2009) Platelet utilization in the developing world: strategies to optimize platelet transfusion practices. IJPM 41:145–149
Kumar ND, Tomas V, Singh B, Kela K (2000) Platlet transfusion practice during dengue fever epidemics. Indian J Pathol Microbiol 43:55–60
Ayyub M, Khazindar AM, Lubbad EH et al (2006) Characteristics of dengue in a large public hospital, Jeddah, Saudi Arabia. J Ayub Medical Coll Abbottabad 18:9–13
Chuansumrit A, Phimolthares V, Tardtong P et al (2000) Transfusion requirements in patients with dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 31:10–14
Lye DC, Lee VJ, Sun Y, Leo YS (2009) Lack of efficacy of prophylactic platelet transfusion for severe thrombocytopenia in adults with acute uncomplicated dengue infection. Clin Infect Dis 48:1262–1265
Sellahewa KH (2008) Management dilemmas in the treatment of dengue fever. Dengue Bull 32:211–218
Chairulfatah A, Setibudi D, Agoes R, Colebunder R (2003) Thrombocytopenia and platelet transfusion in dengue. Haemorrhagic fever and dengue shock syndrome. WHO Dengue Bull 27:141–143
Isarangkura P, Tuchinda S (1993) The behavior of transfused platelets in dengue haemorrhagic fever. Southeast Asian J Trop Med Public Health 24:222–224
Krishnamurti C, Kalyanaraj S, Cutting MA et al (2001) Mechanisms of haemorrhage in dengue without circulatory collapse. Am J Trop Med Hyg 65:840–847
Lum LC, Goh AX, Chan PW et al (2002) Risk factors for severe haemorrhagic in severe dengue infections. J Pediatr 140:629–631
Lum LCS, Abdel-Latif ME, Goh AYT et al (2003) Preventive transfusion in dengue shock syndrome is it necessary? J Pediatr 143:682–684
Chaudhary R, Khethan D, Sinha S, Sinha P, Sonker A, Pandey P et al (2006) Transfusion support to dengue patients in a hospital based blood transfusion service in North India. Transfus Apher Sci 35:239–244
Ahluwalia G, Sharma SK (2004) Dengue current trends and challenges–an Indian perspective. JAPI 52:561–563
World Health Organization (2009) Dengue: guidelines for diagnosis, treatment, prevention and control. World Health Organization, Geneva, pp 40–41
Ministry of Health, Sri Lanka (2005) Guidelines on clinical management of dengue fever/dengue haemorrhagic fever. Epidemiology Unit, Colombo
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pallavi, P., Ganesh, C.K., Jayashree, K. et al. Unfurling the Rationale Use of Platelet Transfusion in Dengue Fever. Indian J Hematol Blood Transfus 27, 70–74 (2011). https://doi.org/10.1007/s12288-011-0059-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-011-0059-1